DNA & Genetics Under Fire from FDA, uniQure Stock Roller-CoastersBy adminMarch 8, 20260 uniQure (NASDAQ: QURE) shares finished the regular trading week down only 9% despite the FDA’s hard-line stance and public criticism…
